Cal Poly student startup sold
A San Luis Obispo startup founded by Cal Poly students has been acquired by a Silicon Valley firm, marking the second sale of a student business from the school in two years. Quest.to, which was founded during a Startup Weekend event in 2012 and then attended the HotHouse summer accelerator program organized by the school’s Read More →
Asta Fluidic takes top spot at UCSB competition
A UC Santa Barbara team developing a cheap and easy technology to test for a serious pregnancy complication is the winner of the school’s 14th annual New Venture Competition. Asta Fluidic Technologies is developing a chip that could drastically reduce the time and cost of testing for fetomaternal hemorrhage, a condition in which the red Read More →
Shopping for shipping: ShipHawk aims to make sending stuff easier
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Don’t mind the gap: Ventura firm’s lightweight motors well-suited to electric cars, drones
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Yardi Systems looks to double sales in three years as it expands into new software niches
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen teams up for Chinese joint venture
Thousand Oaks-based biotech giant Amgen has teamed up with a Chinese company for a joint venture to sell its colorectal cancer drug Vectibix there. Zhejiang Beta Pharma will be 51 percent owner of the the new firm, which will be known as Amgen-Beta Pharmaceuticals. The deal is still subject to approval from Chinese authorities. Amgen’s Read More →
